Extendicare Inc. (TSE:EXE – Get Free Report) declared a monthly dividend on Monday, April 15th, TickerTech reports. Shareholders of record on Tuesday, April 30th will be paid a dividend of 0.04 per share on Wednesday, May 15th. This represents a $0.48 dividend on an annualized basis and a dividend yield of 6.57%. The ex-dividend date of this dividend is Monday, April 29th.
Extendicare Trading Down 0.3 %
EXE opened at C$7.31 on Tuesday. Extendicare has a 12-month low of C$5.75 and a 12-month high of C$7.90. The company has a debt-to-equity ratio of 380.48, a current ratio of 0.83 and a quick ratio of 0.98. The stock has a market capitalization of C$607.90 million, a PE ratio of 18.28 and a beta of 1.22. The firm’s fifty day moving average price is C$7.19 and its 200 day moving average price is C$6.88.
Extendicare (TSE:EXE – Get Free Report) last issued its quarterly earnings results on Thursday, March 7th. The company reported C$0.10 EPS for the quarter. Extendicare had a return on equity of 36.03% and a net margin of 2.60%. As a group, research analysts expect that Extendicare will post 0.3856691 EPS for the current fiscal year.
Analyst Ratings Changes
View Our Latest Analysis on EXE
About Extendicare
Extendicare Inc, through its subsidiaries, provides care and services for seniors in Canada. The company offers long term care (LTC) services; and home health care services, such as nursing care, occupational, physical and speech therapy, and assistance with daily activities, as well as management, consulting, and other services to third parties.
Featured Stories
- Five stocks we like better than Extendicare
- P/E Ratio Calculation: How to Assess Stocks
- Retail Investors Can Follow Goldman Sachs’ Moves This Quarter
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- Johnson & Johnson is as Cheap as it’s Going to Get
- Short Selling: How to Short a Stock
- PayPal’s User Decline Won’t Stop Its Double-Digit Upside
Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.